Foundation of the Belgian Society for Viruses of Microbes and Meeting Report of Its Inaugural Symposium.

Belgian Society for Viruses of Microbes bacteriophages triple helix model

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
22 05 2023
Historique:
received: 16 05 2023
accepted: 18 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

The Belgian Society for Viruses of Microbes (BSVoM) was founded on 9 June 2022 to capture and enhance the collaborative spirit among the expanding community of microbial virus researchers in Belgium. The sixteen founders are affiliated to fourteen different research entities across academia, industry and government. Its inaugural symposium was held on 23 September 2022 in the Thermotechnical Institute at KU Leuven. The meeting program covered three thematic sessions launched by international keynote speakers: (1) virus-host interactions, (2) viral ecology, evolution and diversity and (3) present and future applications. During the one-day symposium, four invited keynote lectures, ten selected talks and eight student pitches were given along with 41 presented posters. The meeting hosted 155 participants from twelve countries.

Identifiants

pubmed: 37243298
pii: v15051213
doi: 10.3390/v15051213
pmc: PMC10221431
pii:
doi:

Types de publication

Congress Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2018 Mar 23;8(1):5091
pubmed: 29572482
Antibiotics (Basel). 2018 Feb 13;7(1):
pubmed: 29438355
Viruses. 2021 Oct 06;13(10):
pubmed: 34696434
Pharmaceutics. 2022 Nov 22;14(12):
pubmed: 36559047
FEMS Microbiol Rev. 2021 Jan 8;45(1):
pubmed: 32897318
Nature. 1976 Apr 8;260(5551):500-7
pubmed: 1264203
Viruses. 2021 Aug 05;13(8):
pubmed: 34452408
Viruses. 2019 Sep 23;11(10):
pubmed: 31548497
Structure. 2020 Jun 2;28(6):613-624.e4
pubmed: 32386574
Viruses. 2018 Feb 06;10(2):
pubmed: 29415431
Viruses. 2023 Jan 06;15(1):
pubmed: 36680214
mSystems. 2022 Oct 26;7(5):e0074122
pubmed: 36069454
Nat Rev Microbiol. 2017 Sep;15(9):517-530
pubmed: 28649138
Bacteriophage. 2012 Jan 1;2(1):1-4
pubmed: 22666651
Microbiol Spectr. 2021 Dec 22;9(3):e0173621
pubmed: 34908439

Auteurs

Agnieszka Latka (A)

Laboratory of Applied Biotechnology, Department of Biotechnology, Faculty of Bioscience Engineering, Ghent University, 9000 Gent, Belgium.
Department of Pathogen Biology and Immunology, University of Wroclaw, 51-148 Wroclaw, Poland.

Abram Aertsen (A)

Laboratory of Food Microbiology, Department of Microbial and Molecular Systems, Faculty of Bioscience Engineering, KU Leuven, 3001 Leuven, Belgium.

Dimitri Boeckaerts (D)

Laboratory of Applied Biotechnology, Department of Biotechnology, Faculty of Bioscience Engineering, Ghent University, 9000 Gent, Belgium.
KERMIT, Department of Data Analysis and Mathematical Modelling, Ghent University, 9000 Ghent, Belgium.

Bob Blasdel (B)

Vésale Bioscience, Vésale Pharmaceutica, 5310 Noville-sur-Mehaigne, Belgium.

Pieter-Jan Ceyssens (PJ)

Division of Human Bacterial Diseases, Sciensano, 1050 Brussels, Belgium.

Abel Garcia-Pino (A)

Cellular and Molecular Microbiology, Faculté des Sciences, Université Libre de Bruxelles, Campus La Plaine, 1050 Brussels, Belgium.

Annika Gillis (A)

Laboratory of Food and Environmental Microbiology, Earth and Life Institute, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.

Rob Lavigne (R)

Laboratory of Gene Technology, Department of Biosystems, Faculty of Bioscience Engineering, KU Leuven, 3001 Leuven, Belgium.

Gipsi Lima-Mendez (G)

Biology of Microorganisms Research Unit (URBM), Namur Research Institute for Life Sciences (NARILIS), Université de Namur ASBL, 5000 Namur, Belgium.

Jelle Matthijnssens (J)

Laboratory of Viral Metagenomics, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.

Jolien Onsea (J)

Department of Trauma Surgery, University Hospitals Leuven, 3000 Leuven, Belgium.
Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.

Eveline Peeters (E)

Research Group of Microbiology, Department of Bioengineering Sciences, Vrije Universiteit Brussel, 1050 Brussels, Belgium.

Jean-Paul Pirnay (JP)

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium.

Damien Thiry (D)

Veterinary Bacteriology, Department of Infectious and Parasitic Diseases, Fundamental and Applied Research for Animals and Health, Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium.

Dieter Vandenheuvel (D)

Department of Bioscience Engineering, University of Antwerp, 2020 Antwerp, Belgium.

Els Van Mechelen (E)

Research Centre Health & Water Technology, University of Applied Sciences, 9000 Gent, Belgium.

Jolien Venneman (J)

Flanders Research Institute for Agriculture, Fisheries and Food (ILVO), 9820 Merelbeke, Belgium.

Gilbert Verbeken (G)

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium.

Jeroen Wagemans (J)

Laboratory of Gene Technology, Department of Biosystems, Faculty of Bioscience Engineering, KU Leuven, 3001 Leuven, Belgium.

Yves Briers (Y)

Laboratory of Applied Biotechnology, Department of Biotechnology, Faculty of Bioscience Engineering, Ghent University, 9000 Gent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH